Latest News

Teva reaches $85 million settlement on eve of opioid trial in Oklahoma

On the eve of a closely watched trial, Teva Pharmaceutical (TEVA) agreed to pay $85 million to settle charges made by the state of Oklahoma of fueling the opioid crisis by overstating the benefits of its opioid painkillers and downplaying addictive risks that led doctors to prescribe the drugs unnecessarily.

The agreement, which must still be finalized, was announced on Sunday, just two days before a trial is scheduled to get under way. However, Oklahoma Attorney General Mike Hunter said the trial will continue as planned against Johnson & Johnson (JNJ), which faces the same claims. Several weeks ago, Purdue Pharma agreed to pay $270 million to settle allegations by the state.

Read the rest…

Source link

Related posts

Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage"


Certain diabetes drugs linked to increased risk of lower limb amputation


A look back at Alphabet's moves in 2019


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy